Events
Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will be presented at the 72nd American Epilepsy Society Annual Meeting (AES 2018) to be held from November 30 to December 4, 2018 in New Orleans in the United States.
Taiwan Liposome Company, Ltd. today announced that it will be attending Goldman Sachs’ Asia Pacific Healthcare Forum in Hong Kong, at the JW Marriott Hotel on November 27-28, 2018.
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, is scheduled to present at the following investor conferences this week.
Both the Chinese and American researchers involved in using CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples in China are under investigation. The work has also received near-universal condemnation worldwide.
Three oral presentations highlighted analyses from the PEPITES Phase III study
Medigene AG today announced its participation at the following upcoming investor and scientific conferences
Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology
Fusion Antibodies plc announces it will release its interim results for the six months ended 30 September 2018 on Monday, 26 November 2018.
Recognized with 2018 Business Innovation Award by MBOT
Event aimed at promoting a culture of innovation and to contribute in effort to achieve objectives of UAE national KPI on Cancer and cardio vascular diseases
PRESS RELEASES